Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis

Annals of Neurology

Volumn 44, Issue 4, 1998, Pages 592-600

  Paul, Robert ^a   Lorenzl, Stefan ^a   Koedel, Uwe ^a   Sporer, Bernd ^a   Vogel, Ulrich ^b   Frosch, Matthias ^b   Pfister, Hans Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EPIDEMIC MENINGITIS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NONHUMAN; PATHOGENESIS; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

ADULT; AGED; ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CEREBROSPINAL FLUID; COLLAGENASES; FEMALE; HUMANS; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASE 9; MENINGITIS, MENINGOCOCCAL; METALLOENDOPEPTIDASES; MIDDLE AGED; PHENYLALANINE; RATS; RATS, WISTAR; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0031723106     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440404     Document Type: Article

References (48)

1. Quagliarello VJ, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992;327: 864-872
2. Pfister HW, Borasio G, Dirnagl U, et al. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992;42: 1497-1504
3. Quagliarello VJ, Scheid WM. Treatment of bacterial meningitis. N Engl J Med 1997;336:708-716
4. Quagliarello VJ, Long WJ, Scheld WM. Morphologic alterations of the blood-brain barrier with experimenral meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest 1986;77:1084-1095
5. Koedel U, Bernatowicz A, Paul R, et al. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol 1995;37:313-323
6. Paul R, Koedel U, Pfister HW. 7-Nitroindazole inhibits pial arteriolar vasodilation in a rat model of pneumococcal meningitis. J Cereb Blood Flow Metab 1997;17:985-991
7. Pfister HW, Koedel U, Lorenzi S, et al. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke 1992;23:1798-1804
8. Koedel U, Pfister HW. Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat. Neurosci Lett 1997;225:33-36
9. Pfister HW, Koedel U, Haberl R, et al. Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab 1990;10:914-922
10. Nadal D, Leppert D, Frei K, et al. Tumor necrosis factor α in infectious meningitis. Arch Dis Child 1989;64:1274-1279
11. Quagliarello VJ, Wispelwey B, Long WJ, et al. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in rat: characterization and comparison with tumor necrosis factor. J Clin Invest 1991;87:1360-1366
12. Halstensen A, Ceska M, Brandtzaeg P, et al. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 1993;167:471-475
13. Koedel U, Bernatowicz A, Frei K, et al. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J Immunol 1996;157:5185-5191
14. Sapsford I, Buontempo J, Weller RO. Basement membrane surfaces and perivascular compartments in normal human brain and glial tumours: a scanning electron microscope study. Neuropathol Appl Neurobiol 1983;9:181-194
15. Vracko R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 1974;77: 314-346
16. Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci USA 1994;732:11-21
17. Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996;49:117-137
18. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;70:163-182
19. Rosenberg GA, Navratil M, Barone FC, et al. Proteolytic cascade enzyme increase in focal cerebral ischemia in rar. J Cereb Blood Flow Metab 1996;16:360-366
20. Rosenberg GA, Dencoff JE, Correa N, et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis. Neurology 1996;46:1626-1632
21. Gijbels K, Masure S, Carton H, et al. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 1992;41: 29-34
22. Giraudon P, Buart S, Bernard A, et al. Extracellular matrix-remodeling metalloproteinases and infection of central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog Neurobiol 1996;49:169-184
23. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995;376:345-355
24. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21
25. Tamura T, Nakanishi T, Kimura Y, et al. Nitric oxide mediates interleukin-1 induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 1996;137:3729-3737
26. Leppert D, Hauser SL, Kishiyama JL, et al. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J 1995;9:1473-1481
27. Rosenberg GA, Kornfeld M, Estrada E, et al. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992;576:203-207
28. Rosenberg GA, Estrada EY, Dencoff JC, et al. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: a expanded therapeutic window. Brain Res 1995;703:151-155
29. Ismair MG, Ries C, Petrides PE. Matrix metalloproteinases and their inhibitors in acute myeloid leukemia. Leukemia 1997; 11(suppl 3):527-529
30. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitors of matrix metalloproteases. J Clin Invest 1994;94:2177-2182
31. Chiviri RGS, Garofalo A, Crimmin MJ, et al. Inhibition of metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994;58:460-464
32. Eccles SA, Box GM, Court WJ, et al. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma with the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 1996;56:2815-2822
33. Meredith JE, Fazeli B, Schwartz S. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993;4:953-961
34. Madri JA, Williams SK. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 1983; 97:153-165
35. Armao D, Kornfeld M, Estrada EY, et al. Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res 1997; 767:259-264
36. Partridge CA, Jeffreys JJ, Malik AB. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am J Physiol 1993;265:L438-L447
37. Olesen SP, Crone C. Substances that rapidly augment ionic conductance of endothelium in cerebral venules. Acta Physiol Scand 1986;127:233-241
38. Butt AM. Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anaesthetized rats. Brain Res 1995;696:145-150
39. Delclaux C, Delacourt C, d'Ortho MP, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996;14:288-295
40. Conway JG, Wakefield JA, Brown RH, et al. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 1995;182:449-457
41. Huber AR, Weiss SJ. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 1989;83:1122-1136
42. Liao F, Huynh HK, Eiroa A, et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 1995;182:1337-1343
43. Hibbs MS, Hasty KA, Seyer JM, et al. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985;260:2493-2500
44. Herron GS, Werb Z, Dwyer K, et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 1986;261:2810-2813
45. Deb S, Gottschall PE. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with β-amyloid peptides. J Neurochem 1996;66: 1641-1647
46. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995;64:1513-1520
47. Gottschall PE. β-Amyloid induction of gelatinase B secretion in cultured microglia: Inhibition by dexamethasone and indomethacin. Neuroreport 1996;7:3077-3080
48. Saukkonen K, Sande S, Cioffe C, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990;171:439-448